Development of dapivirine vaginal ring for HIV prevention

Antiviral Research

Volumn 100, Issue SUPPL., 2013, Pages

  Devlin, Bríd ^a   Nuttall, Jeremy ^a   Wilder, Susan ^a   Woodsong, Cynthia ^a   Rosenberg, Zeda ^a  

^a INTERNATIONAL PARTNERSHIP FOR MICROBICIDES   (United States)

Author keywords

Dapivirine; HIV prevention; Microbicides; Vaginal ring

Indexed keywords

DAPIVIRINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PYRIMIDINE DERIVATIVE; TMC120 R147681; TMC120-R147681;

CLINICAL STUDY; CONSULTATION; CROSS LINKING; DRUG EFFICACY; DRUG SAFETY; DRUG SOLUBILITY; DRUG STRUCTURE; ENZYME ACTIVITY; EPIDEMIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; REVIEW; UNPLANNED PREGNANCY; VAGINA RING; WORKSHOP; ANIMAL; CLINICAL TRIAL (TOPIC); DISEASE TRANSMISSION; DRUG EFFECT; FEMALE; FEMALE CONTRACEPTIVE DEVICE; HIV PREVENTION; HUMAN IMMUNODEFICIENCY VIRUS 1; MICROBICIDES; PHYSIOLOGY; UTILIZATION REVIEW; VIROLOGY; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PIPELINE;

DAPIVIRINE; HIV PREVENTION; MICROBICIDES; VAGINAL RING;

ANIMALS; ANTI-HIV AGENTS; CLINICAL TRIALS AS TOPIC; CONTRACEPTIVE DEVICES, FEMALE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; PYRIMIDINES;

EID: 84889888338     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.09.025     Document Type: Review

References (43)

1. S.A. Abbott, B.A. Friedland, A. Sarna, L.L. Katzen, U. Rawiel, A.K. Srikrishnan, and B.S. Mensch An evaluation of methods to improve the reporting of adherence in a placebo gel trial in Andhra Pradesh India AIDS Behav. 17 6 2013 2222 2236 10.1007/s10461-012-0402-z
2. M.A. Ayman Akil, P. Charlene, S. Dezzutti, J. Bernard, M. Moncla, R. Cost, L. Mingguang, and L.C. Rohan Development and characterization of a vaginal film containing dapivirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI), for prevention of HIV-1 sexual transmission Drug Deliv. Transl. Res. 1 2011 209 222
3. S. Bondurant, F. Virginia, and R. Herman Safety of Silicone Breast Implants: Committee on the Safety of Silicone Breast Implants, Division of Helath Promotion and Disease Prevention 1999 Institute of Medicine Washington, D.C.
4. N. Derby, T. Zydowsky, and M. Robbiani In search of the optimal delivery method for anti-HIV microbicides: are intravaginal rings the way forward? Expert Rev. Anti Infect. Ther. 11 1 2013 5 8 10.1586/eri.12.155
5. S. Di Fabio, J. Van Roey, G. Giannini, G. van den Mooter, M. Spada, A. Binelli, M. Pirillo, E. Germinario, F. Belardelli, M.-P. de Bethune, and S. Vella Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulation AIDS 17 2003 1597 1604 (Pubitemid 36951680)
6. S.M. Fetherston, P. Boyd, C.F. McCoy, M.C. McBride, K.L. Edwards, S. Ampofo, and R.K. Malcolm A silicone elastomer vaginal ring for HIV prevention containing two microbicides with different mechanisms of action Eur. J. Pharm. Sci. 48 3 2012 406 415
7. P. Fletcher, S. Harman, H. Azijn, N. Armanasco, P. Manlow, D. Perumal, M.P. de Bethune, J. Nuttall, J. Romano, and R. Shattock Inhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitor Antimicrobial agents and chemotherapy 53 2 2009 487 495
8. D.R. Friend, and P.F. Kiser Assessment of topical microbicides to prevention HIV-1 transmission: concepts, testing, lessons learned Antiviral Res. 99 3 2013 391 400
9. R.M. Grant, D. Hamer, T. Hope, R. Johnston, J. Lange, M.M. Lederman, C.J. Miller, J.P. Moore, D.E. Mosier, D.D. Richman, R.T. Schooley, M.S. Springer, R.S. Veazey, and M.A. Wainberg Whither or wither microbicides? Science 321 5888 2008 532 534
10. C.A. Hankins, and M.R. Dybul The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review Curr. Opin. HIV AIDS 8 1 2013 50 58
11. E. Hardy, A.L. Jimenez, K.S. de Padua, and L.J. Zaneveld Women's preferences for vaginal antimicrobial contraceptives III: preferences for formulation, applicator, and packaging Contraception 58 4 1998 245 249 (Pubitemid 28565186)
12. P.F. Harrison, Z. Rosenberg, and J. Bowcut Topical microbicides for disease prevention: status and challenges Clin. Infect. Dis. 36 10 2003 1290 1294 (Pubitemid 36629940)
13. J. Holt, A. Leggett, D. Cameron, F. Oostebring, A. Muntendam, L. Rohan, and J. Nuttall Determination of vaginal tissue penetration of dapivirine and tenofovir: an in vivo study in sheep Microbicides 2012
14. I. McGowan Microbicides for HIV prevention: reality or hope? Current opinion in infectious diseases 23 1 2010 26 31
15. Microbicides Trial Network (MTN), 2013. Daily HIV Prevention Approaches Didn't Work for African Women in the VOICE Study. Available from http://www.mtnstopshiv.org/node/4877.
16. E.T. Montgomery, A. van der Straten, H. Cheng, L. Wegner, G. Masenga, C. von Mollendorf, and C. Woodsong Vaginal ring adherence in sub-saharan Africa: expulsion, removal, and perfect use AIDS Behav. 6 7 2012 1787 1798
17. Nel, A., Kamupira, M., Woodsong, C., van der Straten, A., Montgomery, E., Nuttall, J., 2012. Safety, Acceptability and Pharmacokinetic Assessment (Adherence) of Monthly Dapivirine Vaginal Microbicide Rings (Ring-004) for HIV Prevention. Paper presented at the 19th Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, U.S.
18. A.M. Nel, L.B. Mitchnick, P. Risha, L.T. Muungo, and P.M. Norick Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women J. Womens Health. 20 8 2011 1207 1214
19. A.M. Nel, P. Coplan, S.C. Smythe, K. McKord, M. Mitchnick, P.E. Kaptur, and J. Romano Pharmacokinetic assessment of dapivirine vaginal microbicide gel in healthy, HIV-negative women AIDS Res. Hum. Retroviruses. 26 11 2010 1181 1190
20. A.M. Nel, S.C. Smythe, S. Habibi, P.E. Kaptur, and J.W. Romano Pharmacokinetics of 2 dapivirine vaginal microbicide gels and their safety vs. Hydroxyethyl cellulose-based universal placebo gel J. Acquir. Immune Defic. Syndr. 26 11 2010 1181 1190
21. A.M. Nel, P. Coplan, J.H. van de Wijgert, S.H. Kapiga, C. von Mollendorf, E. Geubbels, J. Vyankandondera, H.V. Rees, G. Masenga, I. Kiwelu, J. Moyes, and S.C. Smythe Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women AIDS 23 12 2009 1531 1538
22. A. Nel, S. Smythe, K. Young, K. Malcolm, C. McCoy, Z. Rosenberg, and J. Romano Safety and pharmacokinetics of dapivirine delivery from matrix and reservoir intravaginal rings to HIV-negative women J. Acquir. Immune Defic. Syndr. 51 4 2009 416 423
23. A.R. Neurath, N. Strick, and Y.Y. Li Water dispersible microbicidal cellulose acetate phthalate film BMC Infect. Dis. 3 1 2003 27
24. A. Novak, C. de la Loge, L. Abetz, and E.A. van der Meulen The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability Contraception 67 3 2003 187 194 (Pubitemid 36255655)
25. J. Nuttall, K. Douville, C. Galbreath, S. Walker, P. Norick, and Z. Rosenberg Challenges of producing a drug primarily for use in developing countries: microbicides for HIV prevention Therapy 2007 725 730
26. Nuttall, J., Hettema, W., Van Niekerk, N., Nel, A., 2012. Pharmacokinetics of Monthly Dapivirine Vaginal Microbicide Rings (Ring-004) for HIV Prevention. 2012. Microbicides 2012, Sydney, Australia, April 15-18.
27. J. Nuttall, J. Romano, K. Douville, C. Galbreath, A. Nel, W. Heyward, and Z. Rosenberg The future of HIV prevention: prospects for an effective anti-HIV microbicide Infect. Dis. Clin. North Am. 21 1 2007 219 239 (Pubitemid 46745254)
28. E.G. Raymond, P.L. Chen, S. Condon, J. Luoto, K.T. Barnhart, M.D. Creinin, and R. Blackwell Acceptability of five nonoxynol-9 spermicides Contraception 71 6 2005 438 442 (Pubitemid 40725780)
29. J. Romano, M. Robbiane, G. Doncel, and T. Moench Non-specific microbicide product development: then and now Cur.HIV Res. 10 2013 9 18
30. J. Romano, B. Variano, P. Coplan, J. Van Roey, K. Douville, Z.F. Rosenberg, and M. Mitchnick Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring AIDS Res. Hum. Retroviruses 25 5 2009 483 488
31. Rosenberg, Z.F., Devlin, B., 2012. Future strategies in microbicide development. Best Prac and Res Clin Obs and Gyn. doi: http://dx.doi.org/10.1016/ j.bpobgyn.2012.02.001.
32. Z.F. Rosenberg, A. Nel, W. Heyward, and M. Mitchnick Microbicides for the prevention of HIV infection in women: an overview of recent trials Curr. Opin. HIV AIDS 1 6 2006 514 519
33. B.B. Saxena, Y.A. Han, D. Fu, P. Rathnam, M. Singh, J. Laurence, and S. Lerner Sustained release of microbicides by newly engineered vaginal rings AIDS 23 8 2009 917 922
34. Smith, J.M., Rastogi, R., Teller, R.S., Srinivasan, P., Mesquita, P.M.M., Nagaraja, U., McNicholl, J.M., Hendry, R.M., Dinh, C.T., Martin, A., Herold, B.C., Kiser, P.F. 2013 Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from mulitple vaginal simian-HIV challenges. PNAS Early Edition - published ahead of print September 16, 2013, doi: http://dx.doi.org/10.1073/pnas.1311355110.
35. M. Steiner, A. Spruyt, C. Joanis, L. Glover, M. Cordero, G. Avarado, and C. Onoka Acceptability of spermicidal film and foaming tablets among women in three countries Internat. Fam. Plan. Persp. 21 3 1995 104 107
36. UNAIDS, 2011. AIDS at 30: Nations at the crossroads. http://www.unaids. org/unaids-resources/aidsat30/aids-at-30.pdf.
37. UNAIDS, 2012. UNAIDS Report on the Global AIDS Epidemic. http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/ gr2012/20121120-UNAIDS-Global-Report-2012-with-annexes-en.pdf.
38. L. Van Damme, A. Corneli, K. Ahmed, K. Agot, J. Lombaard, and S. Kapiga Preexposure prophylaxis for HIV infection among African women N. Engl. J. Med. 367 5 2012 411 422
39. A. van der Straten, E.T. Montgomery, H. Cheng, L. Wegner, G. Masenga, C. von Mollendorf, and C. Woodsong High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African women AIDS Behav. 6 7 2012 1775 1786
40. A. van der Straten, E.T. Montgomery, M. Hartmann, and A. Minnis Methodological lessons from clinical trials and the future of microbicide research Curr. HIV/AIDS Rev. 10 1 2013 89 102 10.1007/s11904-012-0141-9
41. Warner Chilcott, 2010. Femring® Full U.S. Prescribing Information (Vol. 2011). http://www.wcrx.com/pdfs/pi/pi-femring.pdf.
42. C. Woodsong, K. MacQueen, R. Amico, B. Friedland, M. Gafos, L. Mansoor, E. Tolley, and S. McCormack Microbicide clinical trial adherence: insights for introduction J. Internat. AIDS Soc. 16 1 2013 18505
43. A.D. Woolfson, R.K. Malcolm, R.J. Morrow, C.F. Toner, and S.D. McCullagh Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide Int. J. Pharm. 325 1-2 2006 82 89 (Pubitemid 44573697)